Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...

As cancer lawsuits cut into profits, Roundup-producer Bayer is behind legislation in 12 states and Congress to shield ...

Bayer (BAYRY) stock gains as the company raises 2025 financial outlook, citing strong pharma performance. Read more here.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

Bayer, which is burdened by U.S. lawsuits claiming that its Roundup weedkiller causes cancer, has said it is holding off on breaking up the diversified group amid calls by some investors to sell the ...

German pharmaceutical and agricultural chemicals giant Bayer said it had put aside an extra 1.2 billion euros ($1.4 billion) ...